Patent US3672738A successfully refreshed from Google Patents.
Patent US5756536A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5756536A Expired / Lapsed US ⏱️ 0.0 years remaining

Microbial transformation of taxol and cephalomannine

Assignee: Purdue Research Foundation
•
Filing: 1996-10-17
•
Granted: 1998-05-26
•
Expires: 2016-10-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A biotransformation process for the production of hydroxylated derivatives of taxol and new derivatives of taxol and cephalomannine are described. A method for converting taxol to L-760,006 and L-760,007, and a method for converting cephalomanine to L-745,596 are provided.

Inventors

  • 👤 Shieh-Shung Tom Chen
  • 👤 Ching-Jer Chang

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 17:56
CPC Classifications
C; C12; C12P; C12P17/00; C12P17/02; C07; C07D; C07D305/00; C07D305/14

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 28 words
A method of converting taxol to L- 760,006 and L-760,007 which comprises: (a) cultivating a microorganism in a medium containing taxol; and (b) recovering the L-760,006 and L-760,007.
Claim 2
Independent Claim 28 words
A method of converting taxol to L- 760,006 and L-760,007 which comprises: (a) cultivating a microorganism in a medium containing taxol; and (b) recovering the L-760,006 and L-760,007.
Claim 3
Dependent Claim 15 words
The method of claim 1 wherein the microorganism is Streptomyces sp. MA 7065 (ATCC 55604).
Claim 4
Dependent Claim 11 words
A compound selected from the group consisting of L-760,006 and L-760,007.
Claim 5
Dependent Claim 11 words
A compound selected from the group consisting of L-760,006 and L-760,007.
Claim 6
Dependent Claim 9 words
A pharmaceutical composition comprising a compound of claim 3.
Claim 7
Dependent Claim 19 words
A method of treating a patient having cancer comprising administration of a compound of claim 3 to the patient.
Claim 8
Independent Claim 23 words
A method of converting cephalomanine to L-745,596, which comprises: (a) cultivating a microorganism in a medium containing cephalomanine; and (b) recovering the L-745,596.
Claim 9
Independent Claim 23 words
A method of converting cephalomanine to L-745,596, which comprises: (a) cultivating a microorganism in a medium containing cephalomanine; and (b) recovering the L-745,596.
Claim 10
Dependent Claim 15 words
The method of claim 1 wherein the microorganism is Streptomyces sp. MA 7065 (ATCC 55604).
Claim 11
Dependent Claim 2 words
Compound L-745,596.
Claim 12
Dependent Claim 2 words
Compound L-745,596.
Claim 13
Dependent Claim 6 words
A pharmaceutical composition comprising compound L-745,596.
Claim 14
Dependent Claim 6 words
A pharmaceutical composition comprising compound L-745,596.
Claim 15
Independent Claim 15 words
A method of treating a patient having cancer comprising administration of L-745,596 to the patient.
Claim 16
Independent Claim 15 words
A method of treating a patient having cancer comprising administration of L-745,596 to the patient.

References Cited (Backward Citations)

US5322779A Cited
US5407674A Cited
WO1995004154A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2001-05-25 2001-11-24 2002-05-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2005-05-25 2005-11-24 2006-05-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2009-05-25 2009-11-24 2010-05-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag